Technical Analysis for ORMP - Oramed Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 3.16 -2.47% -0.08
ORMP closed down 2.47 percent on Thursday, September 19, 2019, on 1.15 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ORMP trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Outside Day Range Expansion 0.00%
Calm After Storm Range Contraction -2.47%
Crossed Above 20 DMA Bullish 0.32%
MACD Bullish Signal Line Cross Bullish 0.32%
Calm After Storm Range Contraction 0.32%
Calm After Storm Range Contraction 4.64%
NR7 Range Contraction 4.64%

Older signals for ORMP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Oramed Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's products primarily comprise ORMD0801, an oral insulin capsule that is in Phase II clinical trials for the treatment of diabetes; and ORMD0901, an analog for GLP-1 gastrointestinal hormone that is in per-clinical trials. Its portfolio of product candidates is based on intellectual property that allows for the protection of proteins and polypeptides in the stomach, and for their absorption through the gastrointestinal wall. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Jerusalem, Israel.
Medicine Chemistry Pharmaceutical Pharmaceutical Industry Diabetes Medication Pharmaceutical Industry In China Endocrine System Dosage Forms Insulin Peptide Hormones Treatment Of Diabetes Glucagon Like Peptide 1 Tablet Pharmaceutical Solutions
Is ORMP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.99
52 Week Low 2.78
Average Volume 49,533
200-Day Moving Average 3.4301
50-Day Moving Average 3.3589
20-Day Moving Average 3.1273
10-Day Moving Average 3.037
Average True Range 0.179
ADX 20.61
+DI 20.8889
-DI 17.8939
Chandelier Exit (Long, 3 ATRs ) 2.813
Chandelier Exit (Short, 3 ATRs ) 3.337
Upper Bollinger Band 3.3995
Lower Bollinger Band 2.8551
Percent B (%b) 0.56
BandWidth 17.407988
MACD Line -0.0644
MACD Signal Line -0.0919
MACD Histogram 0.0276
Fundamentals Value
Market Cap 42.09 Million
Num Shares 13.3 Million
EPS -0.95
Price-to-Earnings (P/E) Ratio -3.33
Price-to-Sales 59.88
Price-to-Book 6.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.54
Resistance 3 (R3) 3.56 3.45 3.47
Resistance 2 (R2) 3.45 3.36 3.44 3.45
Resistance 1 (R1) 3.31 3.30 3.26 3.29 3.43
Pivot Point 3.20 3.20 3.18 3.19 3.20
Support 1 (S1) 3.06 3.11 3.01 3.04 2.89
Support 2 (S2) 2.95 3.05 2.94 2.87
Support 3 (S3) 2.81 2.95 2.85
Support 4 (S4) 2.79